Octavia Wealth Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$913K Sell
2,360
-548
-19% -$203K 0.08% 81
2026
Q1
$851K Buy
2,908
+706
+32% +$232K 0.08% 83
2025
Q4
$771K Buy
2,202
+306
+16% +$103K 0.07% 99
2025
Q3
$613K Buy
1,896
+927
+96% +$288K 0.06% 116
2025
Q2
$377K Sell
969
-81
-8% -$32.6K 0.04% 145
2025
Q1
$457K Buy
+1,050
New +$422K 0.06% 128
2023
Q4
Sell
-676
Closed -$294K 225
2023
Q3
$294K Buy
676
+176
+35% +$79.8K 0.06% 150
2023
Q2
$222K Sell
500
-73
-13% -$33.7K 0.05% 172
2023
Q1
$263K Sell
573
-1
-0.2% -$476 0.06% 149
2022
Q4
$294K Sell
574
-12
-2% -$6.09K 0.07% 140
2022
Q3
$266K Hold
586
0.07% 139
2022
Q2
$282K Buy
586
+23
+4% +$11.4K 0.07% 130
2022
Q1
$277K Buy
563
+5
+0.9% +$2.29K 0.06% 148
2021
Q4
$259K Sell
558
-2
-0.4% -$841 0.06% 168
2021
Q3
$209K Buy
+560
New +$213K 0.05% 173

Other funds holding ELV

Octavia Wealth Advisors's ELV Position: Q2 2026 in Review

Octavia Wealth Advisors reduced its Elevance Health (ELV) stake by 19% in Q2 2026, selling an estimated $203K and leaving 2,360 shares worth $913K. The position accounts for 0.08% of the portfolio, ranked #81.

Octavia Wealth Advisors first reported a position in ELV in Q3 2021 and has held it in 15 quarters since. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Octavia Wealth Advisors held 2,360 shares of Elevance Health worth $913K as of Q2 2026.
  • Octavia Wealth Advisors sold 548 Elevance Health shares in Q2 2026, an estimated $203K.
  • Elevance Health made up 0.08% of Octavia Wealth Advisors's portfolio in Q2 2026, its #81 holding.
  • Octavia Wealth Advisors first reported a position in Elevance Health in Q3 2021 and has held it in 15 quarters since.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Octavia Wealth Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.